Are you tired of missing out on webinars? Introducing XM Live Education, a new platform where you can watch live content on various topics including languages, support, and market updates.

Recently, Pfizer announced that its experimental gene therapy for a muscle-wasting disorder did not meet the main goal of a late-stage trial. This news has raised concerns in the medical community and among investors.

According to a report by Reuters, Pfizer’s gene therapy did not achieve the desired outcome in the trial, leading to a setback in the development of potential treatments for muscle-wasting disorders.

In other news, the German government is reportedly planning a supplementary budget for 2024, US lawmakers are seeking China patent data amid science pact talks, and immigrant rights groups are suing to block Biden’s asylum ban at the Mexico border.

Additionally, a recent study has detailed the significant emissions resulting from Russia’s invasion of Ukraine, shedding light on the environmental impact of geopolitical conflicts.

It is important to note that the information provided by XM Group entities is for educational and informational purposes only. The content available on their Online Trading Facility is not intended to serve as financial advice or a solicitation to enter transactions in the financial markets.

Trading on financial markets carries a high level of risk, and individuals should carefully consider their investment decisions. Any third-party content or analysis provided by XM should be viewed as general market commentary and not as personalized investment advice.

Stay informed with the latest updates on market news, trade ideas, technical summaries, and economic calendars through platforms like XM Live Education to make well-informed decisions in the ever-changing financial landscape.